Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
43.6M
-
Shares change
-
+658K
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$1.21M
-
Put/Call ratio
-
0.28
-
Number of buys
-
26
-
Number of sells
-
-6
-
Price
-
$2.42
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q2 2024
90 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q2 2024.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.6M shares
of 60.7M outstanding shares and own 71.84% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.9M shares), Sands Capital Ventures, LLC (3.42M shares), FRANKLIN RESOURCES INC (3.37M shares), Rock Springs Capital Management LP (2.3M shares), BlackRock Inc. (2.16M shares), FMR LLC (2.02M shares), MILLENNIUM MANAGEMENT LLC (1.95M shares), VANGUARD GROUP INC (1.9M shares), Knollwood Investment Advisory, LLC (1.63M shares), and Laurion Capital Management LP (1.18M shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.